Metrikler
Yayın
150
Açık Erişim
22
BM Sürdürülebilir Kalkınma Amaçları
Duyurular & Dokümanlar
Dosya İndir
Eğitim Bilgileri
2004 - 2010
2004 - 2010Doktora
Marmara Üniversitesi, Sağlık Bilimleri Enstitüsü, Tıbbi Biyoloji Ve Genetik (Dr), Türkiye
2000 - 2003
2000 - 2003Yüksek Lisans
Marmara Üniversitesi, Gastroenteroloji Enstitüsü, Türkiye
Yaptığı Tezler
2010
2010Doktora
Üst Gastrointestinal Sistem Hastalıkları (GİS) ve Mide Kanseri Gelişiminde H. Pylori ve MDR İlişkisi 
Marmara Üniversitesi, Sağlık Bilimleri Enstitüsü, Tıbbi Biyoloji Ve Genetik (Dr)
2003
2003Yüksek Lisans
Lamivudin ve benzeri antiviral tedavisi almamış asemptomatik hepatit B taşıyıcısı ve kronik B hepatit'li hastalarda YMDD motif mutasyonları saptanması ve genotip tayini yapılması
Marmara Üniversitesi, Gastroenteroloji Enstitüsü
Yabancı Diller
C2 Ustalık
C2 Ustalıkİngilizce
Araştırma Alanları
Tıp
Gastroenteroloji-(Hepatoloji)
Tıbbi Genetik
Sağlık Bilimleri
Akademik Unvanlar / Görevler
2021 - Devam Ediyor
2021 - Devam EdiyorProf. Dr.
Marmara Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
2015 - 2021
2015 - 2021Doç. Dr.
Marmara Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
2011 - 2015
2011 - 2015Yrd. Doç. Dr.
Marmara Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
2007 - 2011
2007 - 2011Uzman
Marmara Üniversitesi, Gastroenteroloji Enstitüsü
2001 - 2003
2001 - 2003Araştırma Görevlisi
Marmara Üniversitesi, Gastroenteroloji Enstitüsü
Yönetimsel Görevler
2011 - Devam Ediyor
2011 - Devam EdiyorEnstitü Müdür Yardımcısı
Marmara Üniversitesi, Gastroenteroloji Enstitüsü
Yönetilen Tezler
2024
2024Doktora
Uzun kodlamayan RNA ve mikro RNA'ların hepatoselüler karsinomunun erken tanısında önemi
, Eren F. (Danışman)
D.BİRCAN(Öğrenci)
2024
2024Doktora
Hepatosellüler karsinom hücre hattında n-asetilgalaktozamin ile konjuge oligonükleotit aracılı abcb1-mdr1 gen ifadesinin baskılanmasının in vitro araştırılması
Eren F. (Danışman)
B.HASTÜRK(Öğrenci)
2018
2018Yüksek Lisans
Mitokondriyal MOTS-C geni nükleotit varyasyonlarının nonalkolik yağlı karaciğer hastalığı etyopatogenezi ile ilişkisi
EREN F. (Danışman)
A.ÖNAL(Öğrenci)
2018
2018Yüksek Lisans
Mtnr1b geni nükleotit polimorfizmlarinin nonalkolik yağlı karaciğer hastalığı etyopatogenezi ile ilişkisi
EREN F. (Danışman)
D.YILMAZ(Öğrenci)
2018
2018Yüksek Lisans
İn vitro nonalkolik yağlı karaciğer modelinde mitokondriyal kökenli mots-c peptidinin hastalık etyopatogenezi üzerine etkileri
EREN F. (Danışman)
T.GÖÇMEN(Öğrenci)
2017
2017Yüksek Lisans
Non-alkolik steatohepatit'de mitokondriyal DNA kontrol bölgesi nükleotit varyasyonları ve olası haplotiplerin hastalığın patogeneziyle ilişkisi
EREN F. (Danışman)
B.HASTÜRK(Öğrenci)
2017
2017Yüksek Lisans
Non-alkolik steatohepatit’de mitokondriyal dna kontrol bölgesi nükleotit varyasyonları ve olası haplotiplerin hastalığın patogeneziyle ilişkisi
EREN F. (Danışman)
B.Hastürk(Öğrenci)
2015
2015Yüksek Lisans
İn vitro nonalkolik steatohepatit(NASH) modelinde otofaji ve nash patogenezi üzerine melatoninin etkileri
EREN F. (Danışman)
Y.ZİYA(Öğrenci)
2015
2015Yüksek Lisans
Autophagy in the nonalcoholic steatohepatitis (nash) in vitro model and the effects of melatonin on nash pathogenesis
EREN F. (Danışman)
Y.Ziya(Öğrenci)
2014
2014Yüksek Lisans
Mitokondriyal DNA nikotinamid adenin dinükleotid dehidrogenaz 5 12361 adenin/guanin ve displacement-loop 16189 timin/citozin polimorfizmlerinin nonalkolik steatohepatit hastalarında görülme sıklığı ve klinik önemi
EREN F. (Danışman)
E.GÜNER(Öğrenci)
2013
2013Yüksek Lisans
Nonalkolik yağlı karaciğer hastalığında mitokondriyal nikotinamid adenin dinükleotid dehidrogenaz 5 (nd5) geni mt12361a/g polimorfizminin klinik önemi
EREN F. (Danışman)
M.ORKUN(Öğrenci)
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
2025
20251. Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial
Karahan T. O., Akyuz E. Y., Karadag D. Y., Yılmaz Y., Eren F.
LIFE-BASEL
, sa.5, 2025 (SCI-Expanded)
2024
20242. N-Acetylgalactosamine-Conjugated Antisense Oligonucleotides Designed as Inhibitors of ABCB1: Coping with Multidrug Resistance in Hepatocellular Carcinoma
Hasturk B., Avsar T., Ozbas S., Yilmaz B. K., Eren F.
MOLECULAR BIOLOGY
, cilt.58, sa.6, ss.1280-1292, 2024 (SCI-Expanded)
2024
20243. Production of platelet-rich plasma (PRP)-enriched scaffolds for bone tissue regeneration with 3D printing technology
Arslan Tut T., CESUR S., ŞAHİN A., EREN F., GÜNDÜZ O.
European Polymer Journal
, cilt.219, 2024 (SCI-Expanded)
2024
20244. A therapeutic approach for the hepatitis C virus: in silico design of an antisense oligonucleotide-based candidate capsid inhibitor
Hasturk B., EREN F.
Virus Genes
, cilt.60, sa.5, ss.446-454, 2024 (SCI-Expanded)
2024
20245. Does Genetic Variation in PNPLA3, TM6SF2 and HSD17B13 have a Role in the Development or Prognosis of Hepatocellular Carcinoma in Turkish Patients with Hepatitis B?
DEMİRTAŞ C. Ö., EREN F., YILMAZ D., ÖZDOĞAN O. C., Gunduz F.
Journal of gastrointestinal and liver diseases : JGLD
, cilt.33, sa.2, ss.203-211, 2024 (SCI-Expanded)
2023
20236. Analysis of microbiota profile and nutritional status in male professional football players
Kenger E. B., EREN F., Ozlu T., Gunes F. E.
The Journal of sports medicine and physical fitness
, cilt.63, sa.11, ss.1235-1243, 2023 (SCI-Expanded)
2022
20227. Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index: failure in the prediction of advanced fibrosis in lean and morbidly obese individuals.
Eren F., Kaya E., Yilmaz Y.
European journal of gastroenterology & hepatology
, cilt.34, ss.98-103, 2022 (SCI-Expanded)
2020
20208. Evaluation of the Association between Programmed Cell Death-1 Gene Polymorphisms and Hepatocellular Carcinoma Susceptibility in Turkish Subjects. A Pilot Study
Demirci A. F., Demirtas C. O., Eren F., Yilmaz D., Keklikkiran Ç., Ozdogan O. C., et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
, cilt.29, sa.4, ss.617-622, 2020 (SCI-Expanded)
2020
20209. Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam's razor applied to advanced fibrosis screening.
Yilmaz Y., Kaya E., Eren F.
Alimentary pharmacology & therapeutics
, cilt.52, ss.1759-1760, 2020 (SCI-Expanded)
2020
202010. Effect of carbon dioxide versus room air insufflation on post-colonoscopic pain: A prospective, randomized, controlled study.
Gündüz F., Kani H., Chang S., Akdeniz E., Eren F., Yılmaz Y., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.31, ss.676-680, 2020 (SCI-Expanded)
2020
202011. The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study
Jafarov F., Kaya E., Bakir A., Eren F., Yilmaz Y.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.32, ss.642-649, 2020 (SCI-Expanded)
2020
202012. NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?
Yılmaz Y., Eren F.
ANGIOLOGY
, cilt.71, ss.83-84, 2020 (SCI-Expanded)
2019
201913. Transient elastography for assessing severe hepatic fibrosis in diabetic patients with nonalcoholic fatty liver disease: definitions matter
Yilmaz Y., Eren F.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.31, sa.12, ss.1601-1602, 2019 (SCI-Expanded)
2019
201914. Analysis of 24-Hour Heart Rate Variability among Panic Disorder Patients without Previous Drug Treatment and Comorbid Disorders
Gunduz N., Akpinar Aslan E., EREN F., Sodan Turan H., Ozturk M., Tural U.
TURK PSIKIYATRI DERGISI
, cilt.30, sa.4, ss.236-244, 2019 (SSCI)
2019
201915. Comments on "The Effect of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease"
Yılmaz Y., Eren F.
SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES
, cilt.29, sa.6, ss.548, 2019 (SCI-Expanded)
2019
201916. Potential clinical variants detected in mitochondrial DNA D-loop hypervariable region I of patients with non-alcoholic steatohepatitis
Hasturk B., Yilmaz Y., Eren F.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM
, cilt.18, ss.463-475, 2019 (SCI-Expanded)
2019
201917. Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease
Yilmaz Y., Eren F.
ATHEROSCLEROSIS
, cilt.290, ss.222-223, 2019 (SCI-Expanded)
2019
201918. Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology
YILMAZ Y., EREN F.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.31, sa.1, ss.43-46, 2019 (SCI-Expanded)
2018
201819. THE SEQUENCE ANALYSIS OF NEW MITOCHONDRIALGENE, MOTS-C, IN PATIENTS WITH THE NON-ALCOHOLICSTEATOHEPATITIS
Önal O., Eren F., Yılmaz D., Göçmen T., Yılmaz Y.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL , cilt.6, ss.135, 2018 (SCI-Expanded)
2018
201820. Development of multiplex single base primer extension assay for the detection of potential association between MTNR1B gene polymorphisms and NASH
Yılmaz D., Eren F., Göçmen T., Yılmaz Y.
Journal Of Biotechnology
, cilt.280, ss.76, 2018 (SCI-Expanded)
2017
201721. Nonalcoholic steatohepatitis and gut microbiota: Future perspectives on probiotics in metabolic liver diseases
YILMAZ Y., EREN F.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, sa.5, ss.327-328, 2017 (SCI-Expanded)
2017
201722. Corrigendum to "The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF" [Int. J. Pharm. 478 (2015) 147-154].
Şalva E., Turan S., Eren F., Akbuğa J.
International journal of pharmaceutics
, cilt.520, ss.297, 2017 (SCI-Expanded)
2017
201723. The association of nonalcoholic fatty liver disease with genetic polymorphisms: A multicenter study
Uygun A., Ozturk K., Demirci H., Oztuna A., Eren F., Kozan S., et al.
European Journal of Gastroenterology and Hepatology
, cilt.29, ss.441-447, 2017 (SCI-Expanded)
2015
201524. Associations of IL23R, BMP6 and PTGS1 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis
Ozen G., Deniz R., EREN F., ERZİK C., Unal A. U., Aydin S. Z., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded)
2015
201525. Bactericidal Permeability Increasing Protein Gene Polymorphism is Associated with Inflammatory Bowel Diseases in the Turkish Population
CAN G., Akin H., Ozdemir F. T., Can H., Yilmaz B., EREN F., et al.
SAUDI JOURNAL OF GASTROENTEROLOGY
, cilt.21, sa.4, ss.239-244, 2015 (SCI-Expanded)
2015
201526. ASSOCIATIONS OF ERAP1, IL23R AND PTGER4 POLYMORPHISM WITH RADIOGRAPHIC SEVERITY OF ANKYLOSING SPONDYLITIS
Ozen G., Deniz R., Eren F., Erzik C., Aydin S. Z., Inanc N., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.74, ss.501, 2015 (SCI-Expanded)
2015
201527. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease
ERGELEN R., Akyuz U., Aydin Y., EREN F., YILMAZ Y.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.27, sa.6, ss.667-671, 2015 (SCI-Expanded)
2015
201528. A Systems Genetics Approach to Dyslipidemia in Children and Adolescents
White M. J., EREN F., AĞIRBAŞLI D., Chen J., Hu T., Moore J. H., et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
, cilt.19, sa.4, ss.248-259, 2015 (SCI-Expanded)
2015
201529. SHBG Gene Polymorphism (rs1799941) Associates with Metabolic Syndrome in Children and Adolescents
White M. J., EREN F., AĞIRBAŞLI D., Williams S. M., Agirbasli M.
PLOS ONE
, cilt.10, sa.2, 2015 (SCI-Expanded)
2015
201530. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1 alpha and VEGF
ŞALVA E., Turan S., EREN F., Akbuga J.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.478, sa.1, ss.147-154, 2015 (SCI-Expanded)
2015
201531. Clinical significance of miR-140-5p and miR-193b expression in patients with breast cancer and relationship to IGFBP5
Gullu G., Peker İ., Haholu A., EREN F., Kucukodaci Z., Gulec B., et al.
GENETICS AND MOLECULAR BIOLOGY
, cilt.38, sa.1, ss.21-29, 2015 (SCI-Expanded)
2015
201532. Familial Mediterranean fever gene (MEFV) mutations and disease severity in systemic lupus erythematosus (SLE): implications for the role of the E148Q MEFV allele in inflammation
Deniz R., Ozen G., Yilmaz-Oner S., Alibaz-Oner F., Erzik C., Aydin S. Z., et al.
Lupus
, cilt.24, sa.7, ss.705-711, 2015 (SCI-Expanded)
2014
201433. No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects
Yonal O., EREN F., YILMAZ Y., ATUĞ Ö., Over H. H.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.25, sa.6, ss.639-643, 2014 (SCI-Expanded)
2014
201434. A comparison of FibroMeter (TM) NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease
Aykut U. E., Akyuz U., Yesil A., EREN F., Gerin F., ERGELEN R., et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
, cilt.49, sa.11, ss.1343-1348, 2014 (SCI-Expanded)
2014
201435. A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease
YILMAZ Y., EREN F.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.26, sa.11, ss.1292-1295, 2014 (SCI-Expanded)
2014
201436. The Frequency and the Effects of 21-Hydroxylase Gene Defects in Congenital Adrenal Hyperplasia Patients
Kirac D., GÜNEY A. İ., Akcay T., GÜRAN T., ULUCAN K., Turan S., et al.
ANNALS OF HUMAN GENETICS
, cilt.78, sa.6, ss.399-409, 2014 (SCI-Expanded)
2014
201437. Investigation of the Therapeutic Efficacy of Codelivery of psiRNA-Vascular Endothelial Growth Factor and pIL-4 into Chitosan Nanoparticles in the Breast Tumor Model
ŞALVA E., Turan S., Kabasakal L., Alan S., ÖZKAN N., EREN F., et al.
JOURNAL OF PHARMACEUTICAL SCIENCES
, cilt.103, sa.3, ss.785-795, 2014 (SCI-Expanded)
2014
201438. Factitious disorder and factitious disorder by proxy comorbidity: a case report
EREN F., Oguz N., Yildirim F., Dilbaz N.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY
, cilt.15, 2014 (SCI-Expanded)
2013
201339. Multi-Locus Candidate Gene Analyses of Lipid Levels in a Pediatric Turkish Cohort: Lessons Learned on LPL, CETP, LIPC, ABCA1, and SHBG
Agirbasli M., EREN F., AĞIRBAŞLI D., White M. J., Williams S. M.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
, cilt.17, sa.12, ss.636-645, 2013 (SCI-Expanded)
2013
201340. Prognostic implication of serum vascular endothelial growth factor in advanced hepatocellular carcinoma staging
Yegin E. G., Siykhynnbayev A., EREN F., Bekiroglu N., ÖZDOĞAN O. C.
ANNALS OF HEPATOLOGY
, cilt.12, sa.6, ss.915-925, 2013 (SCI-Expanded)
2013
201341. Sex hormone binding globulin gene polymorphisms and metabolic syndrome in postmenopausal Turkish women
SÜNBÜL M., EREN F., NACAR C., Agirbasli M.
CARDIOLOGY JOURNAL
, cilt.20, sa.3, ss.287-293, 2013 (SCI-Expanded)
2013
201342. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease
YILMAZ Y., Ozturk O., Alandab Y., Senates E., ÇOLAK Y., Doganay H. L., et al.
DIGESTIVE AND LIVER DISEASE
, cilt.45, sa.1, ss.58-62, 2013 (SCI-Expanded)
2013
201343. Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back
YILMAZ Y., ÇOLAK Y., Kurt R., Senates E., EREN F.
TUMORI
, cilt.99, sa.1, ss.10-16, 2013 (SCI-Expanded)
2012
201244. Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis
YILMAZ Y., EREN F.
CLINICA CHIMICA ACTA
, cilt.414, ss.154-157, 2012 (SCI-Expanded)
2012
201245. Hepatic expression and serum levels of syndecan 1 (CD 138) in patients with nonalcoholic fatty liver disease
YILMAZ Y., EREN F., ÇOLAK Y., Senates E., ÇELİKEL Ç., Imeryuz N.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
, cilt.47, sa.12, ss.1488-1493, 2012 (SCI-Expanded)
2012
201246. Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease
Eren F., Kurt R., Ermis F., Atuğ Ö., Imeryuz N., Yılmaz Y.
Clinical Biochemistry
, cilt.45, ss.655-658, 2012 (SCI-Expanded)
2012
201247. Local Delivery of Chitosan/VEGF siRNA Nanoplexes Reduces Angiogenesis and Growth of Breast Cancer In Vivo
Salva E., KABASAKAL L., EREN F., ÖZKAN N., Cakalagaoglu F., Akbuga J.
NUCLEIC ACID THERAPEUTICS
, cilt.22, sa.1, ss.40-48, 2012 (SCI-Expanded)
2012
201248. Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population
Alahdab Y., Eren F., Giral A., Gunduz F., Kedrah A. E., Atug O., et al.
NEUROGASTROENTEROLOGY AND MOTILITY
, cilt.24, sa.1, ss.27-30, 2012 (SCI-Expanded)
2012
201249. Alterations in Serum BDNF Levels in Early Alcohol Withdrawal and Comparison with Healthy Controls
Cavus S. Y., Dilbaz N., Darcin A. E., EREN F., Kaya H., Kaya O.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
, cilt.22, sa.3, ss.210-215, 2012 (SCI-Expanded)
2011
201150. Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: Association with ballooning degeneration
YILMAZ Y., Kurt R., EREN F., Imeryuz N.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
, cilt.71, sa.8, ss.631-636, 2011 (SCI-Expanded)
2011
201151. Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis
YILMAZ Y., EREN F., Ayyildiz T., Colak Y., Kurt R., Senates E., et al.
CLINICA CHIMICA ACTA
, cilt.412, ss.2296-2299, 2011 (SCI-Expanded)
2011
201152. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity
Yilmaz Y., Yonal O., Eren F., Atug O., Hamzaoglu H. O.
Journal of Crohn's and Colitis
, cilt.5, sa.5, ss.402-406, 2011 (SCI-Expanded)
2011
201153. Multimarker Strategies for Detecting NASH and NASH-Related Fibrosis: Promises and Caveats
YILMAZ Y., Kurt R., EREN F.
OBESITY SURGERY
, cilt.21, sa.8, ss.1316-1317, 2011 (SCI-Expanded)
2011
201154. Serum galectin-3 levels in patients with nonalcoholic fatty liver disease
YILMAZ Y., EREN F., Kurt R., Yonal O., Polat Z., Senates E., et al.
CLINICAL BIOCHEMISTRY
, cilt.44, sa.12, ss.955-958, 2011 (SCI-Expanded)
2011
201155. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease
YILMAZ Y., Kurt R., Gurdal A., ÖZEN ALAHDAB Y., Yonal O., Senates E., et al.
ATHEROSCLEROSIS
, cilt.217, sa.1, ss.125-129, 2011 (SCI-Expanded)
2011
201156. The S447X variant of lipoprotein lipase gene is inversely associated with severity of coronary artery disease
Agirbasli M., Sumerkan M. C., EREN F., AĞIRBAŞLI D.
HEART AND VESSELS
, cilt.26, sa.4, ss.457-463, 2011 (SCI-Expanded)
2011
201157. Reply to Aydin et al: "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?"
Yılmaz Y., Eren F.
Metabolism: Clinical and Experimental
, cilt.60, 2011 (SCI-Expanded)
2011
201158. Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy
Agirbasli M., Eren M., EREN F., Murphy S. B., Serdar Z. A., SEÇKİN GENÇOSMANOĞLU D., et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
, cilt.32, sa.1, ss.59-63, 2011 (SCI-Expanded)
2011
201159. Effects of lecithin: Cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels
Agirbasli D., Cirakoglu B., EREN F., Sumerkan M., Aksoy S., Aral C., et al.
JOURNAL OF CLINICAL LIPIDOLOGY
, cilt.5, sa.3, ss.152-158, 2011 (SCI-Expanded)
2011
201160. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease
Aktas B., YILMAZ Y., EREN F., Yonal O., Kurt R., Alandab Y., et al.
METABOLISM-CLINICAL AND EXPERIMENTAL
, cilt.60, sa.4, ss.544-549, 2011 (SCI-Expanded)
2011
201161. Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease
Akin H., Tahan G., Ture F., EREN F., ATUĞ Ö., Tahan V., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.5, sa.1, ss.14-18, 2011 (SCI-Expanded)
2011
201162. Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease
Yılmaz Y., Yonal O., Eren F., Kurt R., Celikel C. A., Ozdogan O., et al.
Clinical Chemistry and Laboratory Medicine
, cilt.49, ss.93-97, 2011 (SCI-Expanded)
2011
201163. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease
Yılmaz Y., Yonal O., Kurt R., Alahdab Y., Eren F., Ozdogan O., et al.
Scandinavian Journal of Gastroenterology
, cilt.46, ss.91-97, 2011 (SCI-Expanded)
2011
201164. Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease
Yılmaz Y., Eren F., Yonal O., Polat Z., Bacha M., Kurt R., et al.
Disease Markers
, cilt.31, ss.205-210, 2011 (SCI-Expanded)
2010
201065. Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B
EREN F., YILMAZ Y., Kose S., Ozdemir F. T., Yonal O., Kurt R., et al.
CLINICA CHIMICA ACTA
, cilt.411, ss.2029-2032, 2010 (SCI-Expanded)
2010
201066. Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease
Yılmaz Y., Yonal O., Kurt R., Oral A. Y., Eren F., Ozdogan O., et al.
Scandinavian Journal of Clinical and Laboratory Investigation
, cilt.70, ss.541-546, 2010 (SCI-Expanded)
2010
201067. R72P Polymorphism of TP53 in Ulcerative Colitis Patients is Associated with the Incidence of Colectomy, Use of Steroids and the Presence of a Positive Family History
EREN F., AKKİPRİK M., ATUĞ Ö., Sonmez O., Tahan G., Ozdemir F., et al.
PATHOLOGY & ONCOLOGY RESEARCH
, cilt.16, sa.4, ss.563-568, 2010 (SCI-Expanded)
2010
201068. The Effect of Lecithin: Cholesterol Acyltransferase Genotypes, Enzyme Levels and Activity on High Density Lipoprotein Levels In Turkish Population
Agirbasli D., Agirbasli M., Eren F., Sumerkan M., Aral C., Aksoy S., et al.
CIRCULATION
, cilt.122, sa.21, 2010 (SCI-Expanded)
2010
201069. Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
YILMAZ Y., Eren F., Yonal O., Kurt R., Aktas B., ÇELİKEL Ç., et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
, cilt.40, sa.10, ss.887-892, 2010 (SCI-Expanded)
2010
201070. Effects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats
Tahan G., Eren F., Tarcin O., Akin H., Tahan V., Sahin H., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.21, sa.3, ss.287-292, 2010 (SCI-Expanded)
2010
201071. The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.
Ozdemir F., Tiftikci A., Sancak S., Eren F., Tahan V., Akın H., et al.
Journal of gastrointestinal cancer
, cilt.41, ss.185-9, 2010 (SCI-Expanded)
2010
201072. Chitosan/Short Hairpin RNA Complexes for Vascular Endothelial Growth Factor Suppression Invasive Breast Carcinoma
Salva E., KABASAKAL L., EREN F., Cakalagaoglu F., ÖZKAN N., Akburga J.
OLIGONUCLEOTIDES
, cilt.20, sa.4, ss.183-190, 2010 (SCI-Expanded)
2010
201073. C-KIT Gene Polymorphism in Achalasia
Alahdab Y. O., EREN F., Gunduz F., Kedrah A. E., YILMAZ Y., Atug O., et al.
GASTROENTEROLOGY
, cilt.138, sa.5, 2010 (SCI-Expanded)
2009
200974. Is HCV Genotyping Cost-Effective Even When the Prevalences of Genotypes 2 and 3 are Low?
Tahan V., Ozaras R., Karaca C., Uraz S., EREN F., Danalioglu A., et al.
HEPATO-GASTROENTEROLOGY
, cilt.56, ss.1425-1428, 2009 (SCI-Expanded)
2009
200975. The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats
Canbakan B., Akin H., Tahan G., Tarcin O., Eren F., Atug O., et al.
ANNALS OF HEPATOLOGY
, cilt.8, sa.3, ss.234-240, 2009 (SCI-Expanded)
2009
200976. Serum Levels of Adipokines in Patients with Chronic HCV Infection: Relationship with Steatosis and Fibrosis
Tiftikci A., ATUĞ Ö., YILMAZ Y., EREN F., Ozdemir F. T., Yapali S., et al.
ARCHIVES OF MEDICAL RESEARCH
, cilt.40, sa.4, ss.294-298, 2009 (SCI-Expanded)
2009
200977. Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats
Tahan V., ATUĞ Ö., Akin H., EREN F., Tahan G., Tarcin O., et al.
JOURNAL OF PINEAL RESEARCH
, cilt.46, sa.4, ss.401-407, 2009 (SCI-Expanded)
2009
200978. GLUCAGON LIKE PEPTIDE-2 DO NOT ALTER SEVERITY OF CARRAGENEAN INDUCED KNEE ARTHRITIS BUT HASTENS ACCOMPANYING INTESTINAL INFLAMMATION IN RATS
KOCAKAYA O., Deniz M., Ozdemir Z. N., Memi G., Bas E., ÇELİKEL Ç., et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES
, cilt.59, ss.540, 2009 (SCI-Expanded)
2008
200879. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARγ) gene in inflammatory bowel disease
ATUĞ Ö., Tahan V., EREN F., Tiftikci A., Imeryuz N., Hamzaoglu H. O., et al.
Journal of Gastrointestinal and Liver Diseases
, cilt.17, sa.4, ss.433-437, 2008 (SCI-Expanded)
2008
200880. Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity
Uraz S., Tahan V., Aygun C., EREN F., Unluguzel G., YÜKSEL M., et al.
DIGESTIVE DISEASES AND SCIENCES
, cilt.53, sa.4, ss.1071-1077, 2008 (SCI-Expanded)
2008
200881. Is there a role for adipocytokines on the effect of anti-TNF treatment in an experimental model of colitis?
Yapali S., Deniz M., EREN F., Imeryuz N., Celikel Ç., Ozkan N., et al.
GASTROENTEROLOGY
, cilt.134, sa.4, 2008 (SCI-Expanded)
2007
200782. Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis
Tahan V., Eren F., Avsar E., Yavuz D., Yuksel M., Emekli E., et al.
DIGESTIVE DISEASES AND SCIENCES
, cilt.52, sa.12, ss.3465-3472, 2007 (SCI-Expanded)
2007
200783. The effects of N-Acetylcysteine on bile duct ligation-induced liver fibrosis in rats
Tahan G., Tarcin O., Tahan V., Eren F., Gedik N., Sahan E., et al.
DIGESTIVE DISEASES AND SCIENCES
, cilt.52, sa.12, ss.3348-3354, 2007 (SCI-Expanded)
2007
200784. Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death
Imeryuz N., Tahan V., Sonsuz A., Eren F., Uraz S., Yuksel M., et al.
JOURNAL OF HEPATOLOGY
, cilt.47, sa.6, ss.851-859, 2007 (SCI-Expanded)
2006
200685. Peptide nucleic acids for the detection of YMDD in chronic hepatitis B.
Eren F., Tahan V., Ozdemir F., Akin H., Tozun N.
Journal of gastrointestinal and liver diseases : JGLD
, cilt.15, ss.320-1, 2006 (SCI-Expanded)
2005
200586. Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey.
Ozdemir F., Duman D., Ertem D., Avşar E., Eren F., Ozdoğan O. C., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.16, ss.183-7, 2005 (SCI-Expanded)
2003
200387. Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.
Tahan V., Avsar E., Karaca C., Uslu E., Eren F., Aydin S., et al.
World journal of gastroenterology
, cilt.9, ss.2325-7, 2003 (SCI-Expanded)
Diğer Dergilerde Yayınlanan Makaleler
2025
20251. Type 2 diabetes risk among master swimmers: a case–control study
ÇELİK Z. M., İSLAMOĞLU A. H., SABUNCULAR G., EREN F., ÖZÜAK A., AKTAÇ Ş.
Nutrire
, cilt.50, sa.1, 2025 (Scopus)
2024
20242. The preliminary data of gene expressions and bioinformatics analysis of miR-146b-5p and miR-4510 in Turkish population in HBV related hepatocellular carcinoma
BİRCAN KADIOĞLU D., DEMİRTAŞ C. Ö., PİRİM D., Gündüz F., EREN F.
Hepatology forum
, cilt.5, ss.106-112, 2024 (ESCI)
2024
20243. The pleiotropic approach to coronavirus disease-19 pathogenesis: The impact of liver diseases associated host genetic variants
ŞAHİN E., DAĞ A., EREN F., EREN F.
Hepatology forum
, cilt.5, sa.2, ss.93-96, 2024 (ESCI)
2023
20234. Relationship Between Nutritional Status, Anthropometric Measurements and Dietary Inflammatory Index in Professional Football Players
Kenger E. B., EREN F., GÜNEŞ F. E.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES
, cilt.13, sa.1, ss.143-149, 2023 (ESCI)
2023
20235. Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis
Sakallı Kani A., Ozercan A., Kani H. T., Eren F., Sayar K., Yılmaz Y.
Hepatology Forum
, cilt.4, sa.3, ss.123-128, 2023 (Scopus)
2023
20236. The International Standards for Neurological Classification of Spinal Cord Injury: Classification Accuracy and Challenges
Snider B. A., EREN F., Reeves R. K., Rupp R., Kirshblum S. C.
TOPICS IN SPINAL CORD INJURY REHABILITATION
, cilt.29, sa.1, ss.1-15, 2023 (ESCI)
2022
20227. The role of myocardial performance index and Nt-proBNP levels as a marker of heart dysfunction in nonalcoholic cirrhotic patients
TOKAY TARHAN S., Yilmaz Enc F., EREN F., FAK A. S., Ozdogan O.
MARMARA MEDICAL JOURNAL
, cilt.35, sa.1, ss.10-16, 2022 (ESCI)
2021
20218. The relationship between polyphenols and miRNAs: A novel therapeutic strategy for metabolic associated fatty liver disease
Bayram H. M., EREN F., Gunes F. E.
HEPATOLOGY FORUM
, cilt.2, sa.3, ss.128-136, 2021 (ESCI)
2020
20209. The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases
Kaya E., Bakır A., Eren F., Yılmaz Y.
Hepatology Forum
, cilt.1, sa.1, ss.8-13, 2020 (Scopus)
2019
201910. The relationship between internet addiction and eating attitudes and obesity related problems among university students
Gunduz N., GÖKÇEN O., EREN F., Erzincan E., Timur O., Turan H., et al.
KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY
, cilt.22, sa.3, ss.266-275, 2019 (ESCI)
2017
201711. Association of ERAP1, IL23R and PTGER4 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis.
Ozen G., Deniz R., Eren F., Erzik C., Unal A., Yavuz S., et al.
The open rheumatology journal
, cilt.11, ss.1-9, 2017 (Scopus)
2014
201412. Frequency and Disease Severity of Familial Mediterranean Fever (FMF) Related MEFV Gene Mutations Among Ankylosing Spondylitis Patients
TUFAN A., AYDIN S. Z., EREN F., ATAGÜNDÜZ M. P.
Türkiye Klinikleri Tip Bilimleri Dergisi
, cilt.34, ss.223-230, 2014 (Scopus)
2010
201013. Epidemiology and diagnosis of hepatitis B in the mediterranean region and elsewhere
Tözün N., Ersoy Ö., EREN F., Tahan V.
NATO Science for Peace and Security Series A: Chemistry and Biology
, ss.239-260, 2010 (Scopus)
2009
200914. MICROSATELLITE INSTABILITY IN THE INFLAMED AND NON-NEOPLASTIC COLONIC MUCOSA IN ULCERATIVE COLITIS
ATUĞ Ö., AKKİPRİK M., EREN F., TIFTIKCI A., Ozdemir F. T., Asicioglu F., et al.
MARMARA MEDICAL JOURNAL
, cilt.22, sa.1, ss.12-18, 2009 (ESCI)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2024
20241. VALIDATION OF MICROBIAL SIGNATURE FOR ADVANCED FIBROSIS IN A GLOBAL MULTI-ETHNIC COHORT OF MASLD
Smirnova E., YILMAZ Y., EREN F., Muthiah M., Oliveira C., Siddiqui M., et al.
The Liver Meeting, California, Amerika Birleşik Devletleri, 15 - 19 Kasım 2024, (Özet Bildiri)
2024
20242. VALIDATION OF AND MECHANISTIC INSIGHTS ON A BILE ACID SIGNATURE OF FIBROSIS PROGRESSION IN METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS
Smirnova E., Kang J., YILMAZ Y., EREN F., Zhou H., Mirshahi F., et al.
The Liver Meeting, California, Amerika Birleşik Devletleri, 15 - 19 Kasım 2024, (Özet Bildiri)
2023
20233. “The gene expressions and bioinformatics analysis of miR-146b-5p and miR-4510 in Hepatocellular Carcinoma”
BİRCAN KADIOĞLU D., DEMİRTAŞ C. Ö., PİRİM D., Gündüz F., EREN F.
EASL Liver Cancer Summit, Estoril, Portekiz, 20 Nisan 2023, ss.134-135, (Özet Bildiri)
2019
20194. MDR1 Gen Polimorfizminin Kolon Kanseri Hastalrında Ekspresyon ve Klinikopatolojik Özelliklerle İlişkisi
Özden G., UPRAK T. K., ATALAY V., EREN F.
17. Türk Kolon ve Rektum Cerrahisi Kongresi, Türkiye, 9 - 13 Nisan 2019, (Özet Bildiri)
2018
20185. İn Vitro Nonalkolik Yağlı Karaciğer Modelinde Mitokondriyal Kökenli MOTS-c Peptidinin Hastalık Etyopatogenezi Üzerine Etkileri
Göçmen T., Eren F., Yılmaz D., Yılmaz Y.
15. Ulusal Hepato Gastroenteroloji Kongresi, Antalya, Türkiye, 10 - 14 Ekim 2018, ss.63-64, (Özet Bildiri)
2017
20176. Preliminary evidence of an association between mtDNA D-loop polymorphisms and the clinicopathological features of nonalcoholic steatohepatitis
Hasturk B., Yılmaz Y., Eren F.
68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 Ekim 2017, cilt.66, (Özet Bildiri)
2017
20177. Nonalcoholic steatohepatitis: modulation of histological phenotype by the missense Thr174Met (rs4762) polymorphism of the angiotensinogen (AGT) gene
EREN F., Balcilar H., Yilmaz D., Toker T., YILMAZ Y., Hasturk B.
68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 Ekim 2017, cilt.66, (Özet Bildiri)
2017
20178. Mitochondrial DNA control region nucleotide variations in non-alcoholic steatohepatitis
Hasturk B., Yılmaz Y., Eren F.
European Biotechnology Congress, Dubrovnik, Hırvatistan, 25 - 27 Mayıs 2017, cilt.256, (Özet Bildiri)
2017
20179. The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study
UYGUN A., öztürk k., demirci h., öztuna a., EREN F., KOZAN S., et al.
JOURNAL OF HEPATOLOGY, Amsterdam, Hollanda, 19 - 23 Nisan 2017, cilt.66, ss.148, (Özet Bildiri)
2017
201710. The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study
Uygun A., Ozturk K., Demirci H., Oztuna A., Eren F., Kozan S., et al.
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Hollanda, 19 - 23 Nisan 2017, cilt.66, (Özet Bildiri)
2016
201611. Türk toplumunda alkolik olmayan yağlı karaciğer hastalığının genetik polimorfizm ile ilişkisi çok merkezli kontrollü çalışma
UYGUN A., öztürk k., DEMİRCİ H., öztuna a., EREN F., YILMAZ Y., et al.
33.Ulusal gastronetroloji haftası, Antalya, Türkiye, 22 - 27 Kasım 2016, (Özet Bildiri)
2016
201612. İrritabl barsak sendromlu hastalarda yüksek laktoz intolerans sıklığı
hasanov r., ÖZEN ALAHDAB Y., EREN F., GÜNDÜZ F., YILMAZ Y., AYKUT U. E.
33.Ulusal gastroenetroloji haftası, Türkiye, 22 - 27 Kasım 2016, (Özet Bildiri)
2016
201613. Bactericidal permeability increasing protein has no effect on remission of ulcerative colitis
EREN F., eroğlu k., Banzragch M., GÜNDÜZ F., ÖZEN ALAHDAB Y., KURT R., et al.
The 4th Annual Meeting of Asian Organization for Crohn's & Colitis, Kyoto, Japonya, 7 - 09 Temmuz 2016
2016
201614. MT ND5 gene variants have both protective and risk factor for inflammatory bowel disease
Eren F., Safarova C., Gündüz F., Özen Alahdab Y., Kurt R., Yılmaz Y., et al.
The 4th Annual Meeting of Asian Organization for Crohn's & Colitis, Kyoto, Japonya, 7 - 09 Temmuz 2016, (Özet Bildiri)
2016
201615. The effect of combination treatment with melatonin and rapamycin on intracellular lipid accumulation in human HepG2 cells
Yaşar Y. Z., Hastürk B., Yılmaz Y., Eren F.
European Human Genetics Conference 2016, Barcelona, İspanya, 21 Mayıs 2016 - 24 Mayıs 2017, ss.143, (Özet Bildiri)
2015
201516. Ülseratif Kolitin ÜK Hastalık Aktivitesi Bakterisidal Permeabilite Arttırıcı Protein BPI Düzeyi ile İlişkilidir
EREN F., EROĞLU K., MUNKHTSETSEG B., ALAHDAB Y. Ö., KURT R., YILMAZ Y., et al.
32. Ulusal Gastroenteroloji Haftası, Türkiye, 25 - 29 Kasım 2015
2015
201517. Ülseratif kolitin hastalık aktivitesi bakterisidal permeabilite arttırıcı protein BPI düzeyi ile ilişkilidir
EREN F., eroğlu k., banzragch m., GÜNDÜZ F., ÖZEN ALAHDAB Y., KURT R., et al.
32. Ulusal Gastroenetroloji Haftası, Türkiye, 25 - 29 Kasım 2015
2015
201518. The anti inflammatory and neuroprotective effects of erythropoietin on hyperbilirubinemic newborn rats
YAMAN A., KOLGAZİ M., MEMİŞOĞLU A., BAHADIR E., ŞİRVANCI S., YEGEN B., et al.
12th World Congress of Perinatal Medicine, 3 - 04 Kasım 2015, (Özet Bildiri)
2015
201519. EFFECTS OF ATORVASTATIN, PIOGLITAZONE AND ERYTHROPOIETIN ON THE EXPRESSIONS OF IRON TRANSPORT MOLECULES IN PHLEBOTOMY-ENHANCED ANEMIA OF RATS WITH CHRONIC KIDNEY DISEASE
KOÇ M., Ozdemir Z., EREN F., Haklar G. G., YEGEN B.
52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation, London, Kanada, 28 - 31 Mayıs 2015, cilt.30, (Özet Bildiri)
2014
201420. Mitokondriyal Nikotinamid Adenin Dinükleotid Dehidrogenaz 5 (ND5) geni 12361A/G nükleotid varyasyonu Nonalkolik Yağlı Karaciğer Hastalığında (NAYKH) Koruyucu mu, Risk Faktörü mü?
Eren F., Orkun M., Akkiprik M., Kılıç K., Güner E., Erzik C., et al.
31. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 25 - 30 Kasım 2014, ss.370, (Özet Bildiri)
2014
201421. Mitokondriyal DNA Displacement-Loop (D-Loop) 16189 Timin/Sitozin Polimorfizmlerinin Non Alkolik Yağlı Karaciğer Hastalarındaki Klinik Önemi ve Yeni RFLP Paterni
Eren F., Güner E., Akkiprik M., Kılıç K., Erzik C., Akın H., et al.
31. Ulusal Gastroentereloji Haftası, Antalya, Türkiye, 25 - 30 Kasım 2014, ss.370, (Özet Bildiri)
2014
201422. FAMILIAL MEDITERRANEAN FEVER GENE (MEFV) MUTATIONS AND DISEASE SEVERITY IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE); IMPLICATIONS ON THE ROLE OF THE E148Q MEFV ALLELE ON INFLAMMATION
Deniz R., Ozen G., Yilmaz-Oner S., Alibaz-Oner F., EREN F., Alhan O., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, ss.320, (Özet Bildiri)
2013
201323. Meme kanserinde miR-140 ve IGFBP-5 ekspresyon düzeyleri arasındaki ilişkinin araştırılması
GÜLLÜ AMURAN G., Peker İ., HAHOLU A., EREN F., KÜÇÜKODACI Z., ERZİK C., et al.
XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Türkiye, 27 - 30 Ekim 2013, (Tam Metin Bildiri)
2013
201324. miR-193b ekspresyon düzeyi ile ERalfa ve IGFBP5 ilişkisinin meme kanserindeki rolü
Peker İ., GÜLLÜ AMURAN G., HAHOLU A., ERZİK C., KÜÇÜKODACI Z., EREN F., et al.
XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Türkiye, 27 - 30 Ekim 2013, (Tam Metin Bildiri)
2013
201325. A Safely Treatment Modality in Wilson's Disease: Liver Transplantation.
TOSUN M., Aydinli B., Ozturk G., Ertekin V., KISAOĞLU A., Ozogul B., et al.
19th Annual International Congress of the International-Liver-Transplantation-Society (ILTS), Sydney, Avustralya, 12 - 15 Haziran 2013, (Özet Bildiri)
2013
201326. Co-Delivery of VEGF siRNA and IL-4 into Chitosan Nanoparticles in Breast Tumor Model of Rat
ŞALVA E., ÖZBAŞ TURAN S., KABASAKAL L., EREN F., Alan S., ÖZKAN N., et al.
16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), Utah, Amerika Birleşik Devletleri, 15 - 18 Mayıs 2013, cilt.21, (Özet Bildiri)
2013
201327. A BIOMARKER PANEL WITH HIGH SENSITIVITY AND SPECIFICITY FOR NONALCOHOLIC STEATOHEPATITIS IDENTIFIED BY SUPPORT VECTOR MACHINE
Yilmaz Y., Eren F.
International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Hollanda, 24 - 28 Nisan 2013, (Özet Bildiri)
2013
201328. HEPATIC EXPRESSION AND SERUM LEVELS OF SYNDECAN 1 (CD138) IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
Yilmaz Y., Eren F., Colak Y., Senates E., Celikel C. A., Imeryuz N.
International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Hollanda, 24 - 28 Nisan 2013, (Özet Bildiri)
2012
201229. Meme Kanserinde miR-140 ve IGFBP-5 Ekspresyon Düzeyleri Arasındaki İlişkinin Araştırılması
GÜLLÜ AMURAN G., Peker İ., HAHOLU A., EREN F., KÜÇÜKODACI Z., ERZİK C., et al.
IV. Multidisipliner Kanser Araştırma Kongresi, Bursa, Türkiye, 13 - 16 Aralık 2012, (Tam Metin Bildiri)
2012
201230. Meme Kanserinde miR-140 ve IGFBP-5 Ekspresyon Düzeyleri Arasındaki İlişkinin Araştırılması
GÜLLÜ AMURAN G., PEKER EYÜBOĞLU İ., HAHOLU A., EREN F., KÜÇÜKODACI Z., ERZİK C., et al.
IV. Multidisipliner Kanser Araştırma Kongresi, Türkiye, 13 - 16 Aralık 2012, (Özet Bildiri)
2012
201231. miR-193b EKSPRESYON DÜZEYİ ile ERalfa ve IGFBP5 İLİŞKİSİNİN MEME KANSERİNDEKİ ROLÜ
Peker İ., GÜLLÜ AMURAN G., HAHOLU A., ERZİK C., KÜÇÜKODACI Z., EREN F., et al.
IV. Multidisipliner Kanser Araştırma Kongresi, Bursa, Türkiye, 13 - 16 Aralık 2012, (Özet Bildiri)
2012
201232. miR-193b EKSPRESYON DÜZEYİ ile ERalfa ve IGFBP5 İLİŞKİSİNİN MEME KANSERİNDEKİ ROLÜ
PEKER EYÜBOĞLU İ., GÜLLÜ AMURAN G., HAHOLU A., ERZİK C., KÜÇÜKODACI Z., EREN F., et al.
IV. Multidisipliner Kanser Araştırma Kongresi, Türkiye, 12 - 14 Aralık 2012, (Özet Bildiri)
2011
201133. The Association Between Bactericidal Permeability Increasing Protein (BPI) Gene Polymorphism and Inflammatory Bowel Diseases, Ulcerative Colitis and Crohn's Disease's Subphenotypes
Can G., Akin H., Ozdemir F. T., Eren F., Atug O., Unsal B., et al.
Conference on Digestive Disease Week 2011, Illinois, Amerika Birleşik Devletleri, 7 - 10 Mayıs 2011, cilt.140, (Özet Bildiri)
2011
201134. Association of MDRI Gene and Helicobacter pylori in the Development of Gastric Cancer and Gastritis
Eren F., Imeryuz N., Bas E., Ozkan N., Ozdemir F. T., Yilmaz Y., et al.
Conference on Digestive Disease Week 2011, Illinois, Amerika Birleşik Devletleri, 7 - 10 Mayıs 2011, cilt.140, (Özet Bildiri)
2011
201135. GG Genotype of SHBG Gene rs1799941 Polymorphism May Indicate Genetic Predisposition to Metobolic Syndrome among Postmenopausal Women
SÜNBÜL M., EREN F., AĞIRBAŞLI M. A.
EPI-NPAM, ATLANTA, Amerika Birleşik Devletleri, 22 - 25 Mart 2011, ss.228-229
2011
201136. SERUM LEVELS OF OSTEOPROTEGERIN IN THE SPECTRUM OF NONALCOHOLIC FATTY LIVER DISEASE
Yilmaz Y., Yonal O., Kurt R., Eren F., Imeryuz N., Kalayci C., et al.
46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Berlin, Almanya, 30 Mart - 03 Nisan 2011, (Özet Bildiri)
2011
201137. CIRCULATING LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGF) AND ITS SOLUBLE RECEPTOR SVEGFR-1 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE
Yilmaz Y., Alahdab Y. O., Kurt R., Yonal O., Eren F., Kalayci C., et al.
46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Berlin, Almanya, 30 Mart - 03 Nisan 2011, (Özet Bildiri)
2010
201038. Chitosan Mediated VEGF shRNA Transfer for the Treatment of Breast Cancer
ŞALVA E., KABASAKAL L., Ozkan N., EREN F., Cakalagaoglu F., Akbuga J.
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, ss.1411, (Özet Bildiri)
2010
201039. MEFV GENE MUTATIONS IN ANKYLOSING SPONDYLITIS: IMPACT ON RADIOGRAPHIC SEVERITY
TUFAN A., EREN F., AYDIN S. Z., DİRESKENELİ R. H., ATAGÜNDÜZ M. P.
Seventh International Congresson Spondyloarthropathies, Belçika, 7 - 09 Ekim 2010, cilt.28, ss.625, (Özet Bildiri)
2009
200940. MELATONIN AMELIORATES METHIONINE CHOLINE DEFICIENT DIET INDUCED NONALCOHOLIC STEATOHEPATITIS IN RATS
Tahan V., ATUĞ Ö., Akin H., EREN F., Tahan G., Tarcin Ö., et al.
60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 30 Ekim - 03 Kasım 2009, cilt.50, (Özet Bildiri)
2009
200941. Prevalence and Genotype Identification of HPV Infection in a Population of Turkish Women
EREN F., Erenus M., BAŞ E., Ahiskali R., Yoldemir T.
98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Massachusetts, Amerika Birleşik Devletleri, 7 - 13 Mart 2009, cilt.89, (Özet Bildiri)
2008
200842. Epidemiology and Diagnosis of Hepatitis B in the Mediterranean Region and Elsewhere
Tozun N., Ersoy O., EREN F., Tahan V.
NATO Advanced Research Workshop on Detection of Bacteria, Viruses, Parasites and Fungi, Perugia, İtalya, 18 - 21 Kasım 2008, ss.239-245, (Tam Metin Bildiri)
2008
200843. Association between Toll-like 4, cd14 polymorphisms and inflammatory bowel disease in Turkish population
Akin H., Oezdemir F. T., Atug O., Tahan G., Eren F., Baca B., et al.
Digestive Disease Week Meeting/109th Annual Meeting of the American-Gastroenterological-Association, California, Amerika Birleşik Devletleri, 17 - 22 Mayıs 2008, cilt.134, (Özet Bildiri)
2006
200644. Glucagon like peptide-1 (GLP-1) ameliorates methionine and choline deficient (MCD) diet induced nonalcoholic steotahepatitis by reducing tissue proinflammatory cytokines
Kedrah A. E., Deniz M., Eren F., Tahan V., Kurtel H., Celikel C., et al.
16th International Symposium on Regulatory Peptides, Hakone, Japonya, 31 Ağustos - 02 Eylül 2006, cilt.135, ss.135-136, (Özet Bildiri)
Kitaplar
2012
20121. Temel Genetik Mekanizmalar
Erzik C., Akkiprik M., Eren F., Özer S. A.
Moleküler Üroloji. Ürolojik Hastalıların Moleküler Temeli, Levent Türkeri,Ayşe Özer,Fehmi Narter, Editör, Üroonkoloji Derneği - Pelin Ofset, İstanbul, ss.123-131, 2012
2010
20102. Epidemiology and Diagnosis of Hepatitis B in the Mediterranean Region and Elsewhere
TÖZÜN A. N., ERSOY Ö., EREN F., veysel t., M V M.
NATO Science for Peace and Security Series A Chemistry and Biology Detection of Bacteria Viruses Parasites and Fungi, Mariapia Viola Magni, Editör, Springer, ss.239-260, 2010
2008
20083. Epidemiology and Diagnosis of Hepatitis B in the Mediterranean Region and Elsewhere
Tözün N., Ersoy Ö., Eren F., Tahan V.
Detection of Bacteria, Viruses, Parasites and Fungi, NATO Science for Peace and Security Series A: Chemistry and Biology, Mariapia Viola Magni, Editör, Springer, London/Berlin , Dordrecht, ss.239-260, 2008
2007
20074. Kronik HBV Enfeksiyonu
Tözün N., Türe Özdemir F., Eren F.
Klinik Gastroenteroloji ve Hepatoloji, Nurdan Tözün,Halis Şimşek,Hasan Özkan,İlkay Şimşek, Editör, Nobel Yayın Dağıtım, Ankara, ss.395-415, 2007
2007
20075. Hepatit C Virüs Enfeksiyonları
Avşar E., Eren F.
Klinik Gastroenteroloji ve Hepatoloji, Nurdan Tözün,Hallis Şimşek,Hasan Özkan,İlkay Şimşek, Editör, Nobel Yayın Dağıtım, Ankara, ss.419-433, 2007
Desteklenen Projeler
2017 - 2018
2017 - 2018Marmara Üniversitesi Hastalıklar ve Tedavi Yaklaşımları 2018-2022 AR-GE strateji belgesi (Hastalıklar ve Tedavi Yaklaşımları)
TÜBİTAK Projesi
Şehirli Ü. S.(Yürütücü), Onat F., Şirvancı S., Akkiprik M., Deniz S., Elçioğlu H. K., et al.
2015 - 2016
2015 - 2016Alkolik olmayan yağlı karaciğer hastalığı AOYKH nda patatin benzeri fosfolipaz 3 PNPLA 3 rs738409 interlökin 28 B IL28B rs12979860 rs12980275 rs8099917 peroksizom proliferatör aktive reseptör PPAR alfa 227 ALA peroksizom proliferatör aktive reseptör PPAR gama pro 12 ALA lektin benzeri okside LDL reseptör 1 IVS4 14 A G LOX IVS4 14 A G ve süperoksit dismutaz 2 C47T SOD2 C47T polimorfizmlerinin AOYKH2 nın ciddiyeti üzerine etkisi
Dernek (STK)
Eren F., Yılmaz Y.
2015 - 2016
2015 - 2016In vitro Nonalkolik steatohepatit modelinde otofaji ve NASH patogenezi üzerine melatonin etkileri
Dernek (STK)
Eren F., Yılmaz Y.
Bilimsel Kuruluşlardaki Üyelikler / Görevler
2022 - Devam Ediyor
2022 - Devam EdiyorTÜBİTAK
Danışma Kurulu Üyesi
Ödüller
Nisan 2012
Nisan 2012